Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.
It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.
There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...
Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...
Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...
Newly appointed CMO, Dr. Emmanuelle Dochy, and newly appointed CSO, Dr. Maurizio Ceppi, bring a strong track record of advancing cancer ...
BT-001 monotherapy showed stable disease and shrinkage of injected lesions in patients with advanced solid tumors. BT-001 in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback